Determination of Metabolic Syndrome among North Indian Adolescents
The current review meant to appraise the commonness of MS utilizing pediatric International Diabetic Federation (IDF) definition and contrast it…
Study on Pattern and Prevalence of Dyslipidemia and Other Cardiovascular Risk Factors among the Various Ethnic Groups of Trinidad and Tobago
Background: Dyslipidemia is a crucial component of the metabolic syndrome and has long been linked to the development of issues…
Determining the Factors Associated with Prognosis of Non-Alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease (NAFLD) is a condition that occurs at the intersection of obesity, metabolic syndrome, and liver failure.…
Determination of Diabetes and Dyslipidemia Goals in the Management of Diabetes
Diabetes Type I and Type II have an increased risk of early atherosclerotic CVD, such as CHD and PAD [1],…
Encapsulation of Anti-dyslipidemic Drug as a Controlled Release Tablet Using Proanthocyanidin Polymer
Many people today are at high risk of coronary heart disease, and few drugs are available to assist them achieve…
Profiling Lipids in People Living with HIV Receiving Antiretroviral Therapy at Mpilo Central Hospital OIC: Hitherto Going Forth?
Introduction: Long term use of antiretroviral therapy subpopulation living with HIV is associated with disturbances in plasma lipids concentrations. Lipids…
Consensus Summit: Lipids and Cardiovascular Health in the Nigerian Population
Aims: To issue a consensus statement on Lipids and Cardiovascular Health and the impact of their interrelationship in Nigerian Population.…
Effect of Cymbopogon citratus Stapf (DC) on Type 2 Diabetes Mellitus-induced Dyslipidemia: Current Knowledge
Introduction: Diabetic dyslipidemia (DD) is a collection of quantitative, qualitative and kinetic lipid abnormalities associated with diabetes mellitus that together…